Antioxidants of interest in clinical and pre-clinical assessment of NAFLD/NASH include GSH, SOD, CAT, and GPx, which appear to be most reliably detected in liver samples. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatotic liver disease.